Update: 14.11.2022
Last week: 44 week 2022 (31.10.2022 - 06.11.2022)
Last full month: October 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 128 128 | -6.6% | 3.4% | -0.3 | 28 668 838 | -4.1% | 3.6% | -0.2 | 0.4% |
| MoM | 663 634 | -11.2% | 3.7% | 0 | 141 897 078 | -7.6% | 3.9% | 0.1 | -11.7% |
| YTD | 8 448 166 | -21.4% | 5.2% | -1.2 | 1 688 895 410 | -7.8% | 5.1% | -0.7 | -3.9% |
| MAT | 10 963 360 | -8.0% | 5.4% | -0.2 | 2 147 755 052 | 6.1% | 5.2% | 0.1 | -4.2% |
| DEXALGIN | |||||||||
| WoW | 15 034 | -14.7% | 0.4% | -0.1 | 7 372 475 | -17.1% | 1.1% | -0.2 | -1.5% |
| MoM | 86 956 | -4.2% | 0.4% | 0 | 43 128 669 | -0.4% | 1.4% | 0.2 | -15.1% |
| YTD | 1 440 678 | -1.2% | 0.7% | 0 | 615 348 255 | 11.1% | 1.8% | 0 | -0.3% |
| MAT | 1 821 595 | 4.5% | 0.7% | 0 | 762 496 094 | 15.6% | 1.9% | 0.1 | -1.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 50 377 | -2.4% | 42.5% | -0.7 | 26 705 767 | -1.5% | 49.3% | -0.6 | -0.7% |
| MoM | 239 485 | -14.9% | 42.7% | -3.6 | 125 979 753 | -15.3% | 49.0% | -3 | -7.8% |
| YTD | 3 837 981 | -13.1% | 54.9% | -11.6 | 1 954 926 248 | -2.8% | 60.5% | -10.1 | 5.2% |
| MAT | 4 702 774 | -9.6% | 56.3% | -9.8 | 2 367 926 040 | 1.1% | 61.9% | -8.5 | 6.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 325 | 2.5% | 32.0% | 0.5 | 13 831 337 | 2.5% | 45.3% | 0.3 | 0.9% |
| MoM | 100 666 | -10.7% | 32.4% | -2.5 | 65 668 391 | -11.0% | 45.8% | -2.4 | -3.7% |
| YTD | 1 237 158 | -13.0% | 37.7% | -4.1 | 773 957 987 | -6.6% | 50.9% | -5.6 | -3.6% |
| MAT | 1 478 915 | -14.3% | 37.9% | -3.9 | 917 102 338 | -7.5% | 51.4% | -4.9 | -5.6% |
| FASTUM | |||||||||
| WoW | 14 998 | 7.4% | 0.9% | 0.1 | 8 474 121 | 7.8% | 2.3% | 0.1 | -2.3% |
| MoM | 64 329 | -16.9% | 0.8% | -0.1 | 36 346 604 | -13.8% | 2.1% | -0.1 | -7.5% |
| YTD | 912 015 | -23.6% | 1.1% | -0.3 | 473 180 494 | -13.7% | 2.5% | -0.6 | -0.0% |
| MAT | 1 103 689 | -23.2% | 1.2% | -0.3 | 564 812 353 | -13.8% | 2.6% | -0.6 | -1.1% |
| IODOMARIN | |||||||||
| WoW | 66 485 | -10.1% | 23.4% | -0.4 | 12 351 528 | -9.6% | 10.0% | -0.4 | -8.6% |
| MoM | 358 258 | 6.7% | 24.2% | -0.2 | 66 228 362 | 6.5% | 10.6% | -0.2 | 7.5% |
| YTD | 2 750 490 | 5.7% | 20.2% | 0 | 539 922 753 | 10.5% | 9.1% | -0.1 | 5.7% |
| MAT | 3 314 591 | 15.8% | 20.6% | 1.8 | 643 848 307 | 18.4% | 9.3% | 0.7 | 5.8% |
| LIOTON | |||||||||
| WoW | 13 621 | -6.1% | 1.5% | -0.1 | 15 163 532 | -8.9% | 3.5% | -0.4 | -0.6% |
| MoM | 68 286 | -18.3% | 1.6% | -0.2 | 75 928 498 | -15.9% | 3.8% | -0.1 | -7.2% |
| YTD | 1 121 649 | -24.3% | 2.3% | -0.5 | 1 154 770 253 | -5.1% | 4.7% | -0.9 | -7.1% |
| MAT | 1 332 485 | -22.0% | 2.3% | -0.4 | 1 341 008 448 | -3.4% | 4.8% | -0.8 | -7.5% |
| MEZYM | |||||||||
| WoW | 194 537 | -0.8% | 18.1% | -0.6 | 28 911 982 | -2.0% | 12.7% | -0.8 | 2.4% |
| MoM | 920 938 | -9.0% | 18.8% | -0.1 | 140 372 345 | -9.1% | 13.5% | 0.2 | -8.4% |
| YTD | 15 503 283 | -9.0% | 26.5% | -2.1 | 2 370 275 014 | -0.6% | 19.0% | -2.4 | -1.9% |
| MAT | 19 223 343 | -5.0% | 27.4% | -1.1 | 2 895 100 588 | 2.4% | 19.7% | -1.7 | -1.3% |
| MIG 400 | |||||||||
| WoW | 124 095 | 0.7% | 2.9% | 0.1 | 15 005 163 | 0.9% | 2.3% | 0 | -1.5% |
| MoM | 590 420 | -16.3% | 2.8% | 0 | 71 281 785 | -15.1% | 2.2% | 0 | -15.1% |
| YTD | 7 284 563 | -13.8% | 3.3% | -0.5 | 858 740 509 | -9.7% | 2.5% | -0.6 | -0.3% |
| MAT | 8 723 639 | -11.4% | 3.3% | -0.4 | 1 023 956 933 | -7.5% | 2.6% | -0.4 | -1.7% |
| PROSTAMOL | |||||||||
| WoW | 20 650 | 2.1% | 14.1% | 0.2 | 28 153 589 | 1.7% | 14.8% | 0.3 | 1.0% |
| MoM | 104 788 | -2.2% | 15.4% | 0.3 | 144 315 206 | -3.2% | 16.3% | 0.2 | -4.2% |
| YTD | 1 356 737 | -25.8% | 19.0% | -6.1 | 1 900 004 335 | -17.1% | 20.3% | -7 | -2.1% |
| MAT | 1 669 015 | -22.7% | 19.5% | -5 | 2 308 024 133 | -14.3% | 20.8% | -5.9 | -2.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 19 294 | -1.3% | 6.7% | -0.1 | 9 412 964 | -2.4% | 7.0% | -0.1 | -0.1% |
| MoM | 99 923 | -10.4% | 7.6% | -0.1 | 48 921 001 | -8.4% | 7.9% | -0.1 | -9.0% |
| YTD | 1 047 319 | 100.2% | 8.7% | 4.3 | 492 272 407 | 100.3% | 8.6% | 3.9 | 0.5% |
| MAT | 1 271 095 | 103.9% | 8.6% | 4.3 | 591 427 911 | 101.2% | 8.5% | 3.8 | 1.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 448 166 | -21.4% | 5.2% | -1.2 | 1 688 895 410 | -7.8% | 5.1% | -0.7 | -3.9% |
| DEXALGIN | 1 440 678 | -1.2% | 0.7% | 0 | 615 348 255 | 11.1% | 1.8% | 0 | -0.3% |
| ESPUMISAN (ADULTS) | 3 837 981 | -13.1% | 54.9% | -11.6 | 1 954 926 248 | -2.8% | 60.5% | -10.1 | 5.2% |
| ESPUMISAN BABY | 1 237 158 | -13.0% | 37.7% | -4.1 | 773 957 987 | -6.6% | 50.9% | -5.6 | -3.6% |
| FASTUM | 912 015 | -23.6% | 1.1% | -0.3 | 473 180 494 | -13.7% | 2.5% | -0.6 | -0.0% |
| IODOMARIN | 2 750 490 | 5.7% | 20.2% | 0 | 539 922 753 | 10.5% | 9.1% | -0.1 | 5.7% |
| LIOTON | 1 121 649 | -24.3% | 2.3% | -0.5 | 1 154 770 253 | -5.1% | 4.7% | -0.9 | -7.1% |
| MEZYM | 15 503 283 | -9.0% | 26.5% | -2.1 | 2 370 275 014 | -0.6% | 19.0% | -2.4 | -1.9% |
| MIG 400 | 7 284 563 | -13.8% | 3.3% | -0.5 | 858 740 509 | -9.7% | 2.5% | -0.6 | -0.3% |
| PROSTAMOL | 1 356 737 | -25.8% | 19.0% | -6.1 | 1 900 004 335 | -17.1% | 20.3% | -7 | -2.1% |
| RESPERO MYRTOL | 1 047 319 | 100.2% | 8.7% | 4.3 | 492 272 407 | 100.3% | 8.6% | 3.9 | 0.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 10 963 360 | -8.0% | 5.4% | -0.2 | 2 147 755 052 | 6.1% | 5.2% | 0.1 | -4.2% |
| DEXALGIN | 1 821 595 | 4.5% | 0.7% | 0 | 762 496 094 | 15.6% | 1.9% | 0.1 | -1.7% |
| ESPUMISAN (ADULTS) | 4 702 774 | -9.6% | 56.3% | -9.8 | 2 367 926 040 | 1.1% | 61.9% | -8.5 | 6.2% |
| ESPUMISAN BABY | 1 478 915 | -14.3% | 37.9% | -3.9 | 917 102 338 | -7.5% | 51.4% | -4.9 | -5.6% |
| FASTUM | 1 103 689 | -23.2% | 1.2% | -0.3 | 564 812 353 | -13.8% | 2.6% | -0.6 | -1.1% |
| IODOMARIN | 3 314 591 | 15.8% | 20.6% | 1.8 | 643 848 307 | 18.4% | 9.3% | 0.7 | 5.8% |
| LIOTON | 1 332 485 | -22.0% | 2.3% | -0.4 | 1 341 008 448 | -3.4% | 4.8% | -0.8 | -7.5% |
| MEZYM | 19 223 343 | -5.0% | 27.4% | -1.1 | 2 895 100 588 | 2.4% | 19.7% | -1.7 | -1.3% |
| MIG 400 | 8 723 639 | -11.4% | 3.3% | -0.4 | 1 023 956 933 | -7.5% | 2.6% | -0.4 | -1.7% |
| PROSTAMOL | 1 669 015 | -22.7% | 19.5% | -5 | 2 308 024 133 | -14.3% | 20.8% | -5.9 | -2.9% |
| RESPERO MYRTOL | 1 271 095 | 103.9% | 8.6% | 4.3 | 591 427 911 | 101.2% | 8.5% | 3.8 | 1.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 128 128 | -6.6% | 3.4% | -0.3 | 28 668 838 | -4.1% | 3.6% | -0.2 | 0.4% |
| DEXALGIN | 15 034 | -14.7% | 0.4% | -0.1 | 7 372 475 | -17.1% | 1.1% | -0.2 | -1.5% |
| ESPUMISAN (ADULTS) | 50 377 | -2.4% | 42.5% | -0.7 | 26 705 767 | -1.5% | 49.3% | -0.6 | -0.7% |
| ESPUMISAN BABY | 21 325 | 2.5% | 32.0% | 0.5 | 13 831 337 | 2.5% | 45.3% | 0.3 | 0.9% |
| FASTUM | 14 998 | 7.4% | 0.9% | 0.1 | 8 474 121 | 7.8% | 2.3% | 0.1 | -2.3% |
| IODOMARIN | 66 485 | -10.1% | 23.4% | -0.4 | 12 351 528 | -9.6% | 10.0% | -0.4 | -8.6% |
| LIOTON | 13 621 | -6.1% | 1.5% | -0.1 | 15 163 532 | -8.9% | 3.5% | -0.4 | -0.6% |
| MEZYM | 194 537 | -0.8% | 18.1% | -0.6 | 28 911 982 | -2.0% | 12.7% | -0.8 | 2.4% |
| MIG 400 | 124 095 | 0.7% | 2.9% | 0.1 | 15 005 163 | 0.9% | 2.3% | 0 | -1.5% |
| PROSTAMOL | 20 650 | 2.1% | 14.1% | 0.2 | 28 153 589 | 1.7% | 14.8% | 0.3 | 1.0% |
| RESPERO MYRTOL | 19 294 | -1.3% | 6.7% | -0.1 | 9 412 964 | -2.4% | 7.0% | -0.1 | -0.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 663 634 | -11.2% | 3.7% | 0 | 141 897 078 | -7.6% | 3.9% | 0.1 | -11.7% |
| DEXALGIN | 86 956 | -4.2% | 0.4% | 0 | 43 128 669 | -0.4% | 1.4% | 0.2 | -15.1% |
| ESPUMISAN (ADULTS) | 239 485 | -14.9% | 42.7% | -3.6 | 125 979 753 | -15.3% | 49.0% | -3 | -7.8% |
| ESPUMISAN BABY | 100 666 | -10.7% | 32.4% | -2.5 | 65 668 391 | -11.0% | 45.8% | -2.4 | -3.7% |
| FASTUM | 64 329 | -16.9% | 0.8% | -0.1 | 36 346 604 | -13.8% | 2.1% | -0.1 | -7.5% |
| IODOMARIN | 358 258 | 6.7% | 24.2% | -0.2 | 66 228 362 | 6.5% | 10.6% | -0.2 | 7.5% |
| LIOTON | 68 286 | -18.3% | 1.6% | -0.2 | 75 928 498 | -15.9% | 3.8% | -0.1 | -7.2% |
| MEZYM | 920 938 | -9.0% | 18.8% | -0.1 | 140 372 345 | -9.1% | 13.5% | 0.2 | -8.4% |
| MIG 400 | 590 420 | -16.3% | 2.8% | 0 | 71 281 785 | -15.1% | 2.2% | 0 | -15.1% |
| PROSTAMOL | 104 788 | -2.2% | 15.4% | 0.3 | 144 315 206 | -3.2% | 16.3% | 0.2 | -4.2% |
| RESPERO MYRTOL | 99 923 | -10.4% | 7.6% | -0.1 | 48 921 001 | -8.4% | 7.9% | -0.1 | -9.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs